Form preview

Get the free Form FDA 1571 - Investigational New Drug Application

Get Form
We are not affiliated with any brand or entity on this form
Illustration
Fill out
Complete the form online in a simple drag-and-drop editor.
Illustration
eSign
Add your legally binding signature or send the form for signing.
Illustration
Share
Share the form via a link, letting anyone fill it out from any device.
Illustration
Export
Download, print, email, or move the form to your cloud storage.

Why pdfFiller is the best tool for your documents and forms

GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

End-to-end document management

From editing and signing to collaboration and tracking, pdfFiller has everything you need to get your documents done quickly and efficiently.

Accessible from anywhere

pdfFiller is fully cloud-based. This means you can edit, sign, and share documents from anywhere using your computer, smartphone, or tablet.

Secure and compliant

pdfFiller lets you securely manage documents following global laws like ESIGN, CCPA, and GDPR. It's also HIPAA and SOC 2 compliant.
Form preview

What is FDA 1571 IND

The Form FDA 1571 is a government document used by sponsors to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA).

pdfFiller scores top ratings on review platforms

Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Show more Show less
Fill fillable FDA 1571 IND form: Try Risk Free
Rate free FDA 1571 IND form
4.9
satisfied
52 votes

Who needs FDA 1571 IND?

Explore how professionals across industries use pdfFiller.
Picture
FDA 1571 IND is needed by:
  • Pharmaceutical companies seeking IND approval.
  • Research organizations conducting clinical trials.
  • Clinical investigators managing drug investigations.
  • Authorized representatives acting on behalf of sponsors.
  • Professionals involved in drug development processes.
  • Regulatory affairs specialists ensuring compliance.

Comprehensive Guide to FDA 1571 IND

What is Form FDA 1571 - Investigational New Drug Application?

Form FDA 1571 is crucial for submitting an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA). This document is utilized by various sponsors, which may include individuals, pharmaceutical companies, or other entities. Completing this form is necessary for anyone intending to conduct drug clinical investigations. The form requires specific data about the drug and the phases of clinical investigation, making it a vital component of the drug approval process.
The form must be filled out by the primary sponsor or an authorized representative, ensuring that all required signatures are obtained. By understanding its significance, stakeholders can navigate the regulatory landscape more effectively.

Purpose and Benefits of Form FDA 1571 - IND Application

Submitting Form FDA 1571 serves several important purposes. It is essential for compliance with federal regulations governing drug development. Moreover, timely submission can facilitate a smoother drug approval process, significantly impacting potential market entry.
Utilizing the IND application form enhances compliance with regulatory standards while potentially providing marketing advantages. By ensuring that all necessary documentation is submitted, sponsors can better position their products in a competitive market.

Key Features of Form FDA 1571

Form FDA 1571 contains several critical components that users must be familiar with. It features specific fillable fields, requiring complete and accurate information from sponsors.
  • Required signatures from sponsors and authorized representatives.
  • Detailed sections for drug information, including clinical investigation phases.
  • Submission details, including deadlines and methods.
Understanding these features aids in accurately completing the form, thus maximizing the chances of successful submissions.

Who Needs to Complete Form FDA 1571?

The responsibility for completing Form FDA 1571 lies primarily with the primary sponsor, who must have a comprehensive understanding of the application process. Authorized representatives also play a critical role, facilitating communication between the sponsor and the FDA.
Additionally, countersigners may be required to validate the application. Knowing the eligibility criteria and roles involved in submitting the form is essential for efficient application processing.

How to Fill Out Form FDA 1571 - Step-by-Step Guide

Filling out Form FDA 1571 can be straightforward when following clear, structured steps. Begin by gathering all necessary information about the drug and clinical investigation. Next, complete each section methodically.
  • Provide the sponsor's name and address in the designated fields.
  • Detail the proposed drug and clinical investigation phases.
  • Ensure that all required signatures are obtained before submission.
By adhering to these instructions and paying close attention to detail, the likelihood of making common mistakes diminishes.

Submission Methods for Form FDA 1571

Once Form FDA 1571 is completed, it must be submitted to the FDA through approved methods. The options for submission include online, by mail, or via fax.
  • Online submissions allow for immediate processing and acknowledgment.
  • Mail submissions may require additional time for delivery and processing.
  • Fax submissions can provide a quick alternative but may not be suitable for all applications.
Each method has its own set of fees, deadlines, and expected processing times that should be reviewed beforehand to ensure timely submission.

What Happens After You Submit Form FDA 1571?

After submitting Form FDA 1571, sponsors can expect the FDA to initiate a review of the application. This process includes evaluating the application for completeness and accuracy.
Common timelines for communication can vary, but applicants should stay informed about their application's status and understand possible reasons for rejection. Keeping track of these aspects can help mitigate delays in the approval process.

Security and Compliance When Submitting Form FDA 1571

Submitting sensitive information via Form FDA 1571 necessitates robust security measures. The form's submission process employs advanced data protection protocols, like 256-bit encryption, to safeguard user information.
It's also vital to consider compliance with regulations such as HIPAA and GDPR, ensuring that all personal data is handled with care and in accordance with legal standards.

Fill Out Form FDA 1571 Easily with pdfFiller

Utilizing pdfFiller can greatly simplify the process of filling out Form FDA 1571. This platform is designed for effortless editing and secure form handling.
  • Leverage features for editing and creating fillable forms.
  • Utilize secure eSign capabilities to complete the application seamlessly.
Through the advantages offered by pdfFiller, users can enhance their form-filling experience, making the submission process more efficient and secure.
Last updated on Mar 18, 2015

How to fill out the FDA 1571 IND

  1. 1.
    To access the Form FDA 1571 on pdfFiller, visit the website and use the search bar to find 'Form FDA 1571'. Once located, click on the form to open it in pdfFiller's editing interface.
  2. 2.
    Navigate through the document using the scrolling feature. Click on each fillable field to enter the necessary information. Utilize the tools on pdfFiller to zoom in or out for better visibility.
  3. 3.
    Before starting to fill out the form, gather essential information such as your name, organization details, drug information, and specifics related to the clinical investigation phases.
  4. 4.
    After entering the required information, review the completed fields carefully for accuracy. Use the preview option to ensure everything appears as intended.
  5. 5.
    Finalize the form by checking all entries for completeness. If needed, make any corrections before proceeding.
  6. 6.
    To save your completed form, click on the 'Save' button. You can also download a copy to your computer or device for your records.
  7. 7.
    If you wish to submit the form directly to the FDA, use the submission option available on pdfFiller, following the prompts to send it securely.
Regular content decoration

FAQs

If you can't find what you're looking for, please contact us anytime!
Form FDA 1571 is intended for sponsors of clinical investigations, which can include individual researchers, pharmaceutical companies, and research organizations who intend to conduct clinical trials.
There is no specific deadline; however, Form FDA 1571 should be submitted before starting any investigational new drug study to ensure timely approval from the FDA.
The completed Form FDA 1571 can be submitted electronically through the FDA's submission portal or mailed in accordance with FDA guidelines. Ensure you follow the submission instructions provided by the FDA.
Typically, sponsors must include a comprehensive clinical study protocol and any additional documents related to drug safety, efficacy data, and previous investigational results to support the IND application.
Common mistakes include omitting required fields, providing inaccurate drug information, and failing to obtain necessary signatures. Always double-check your entries for completeness and accuracy.
Processing times can vary; however, sponsors can expect to receive a response from the FDA within a few weeks after submission, depending on the complexity of the application and workload at the agency.
There are generally no fees for submitting Form FDA 1571; however, other associated fees may apply during the drug approval process, such as those related to clinical trials.
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.